Seven Eight Capital, LP Schrodinger, Inc. Transaction History

Seven Eight Capital, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$21.62 - $37.21 $302,852 - $521,237	-14,008 Reduced 39.13%	21,790 $780,000
Q3 2023 Nov 14, 2023	BUY	$27.34 - $55.37 $978,717 - $1.98 Million	35,798 New	35,798 $1.01 Million
Q1 2022 May 11, 2022	SELL	$24.84 - $36.12 $261,888 - $380,813	-10,543 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$33.38 - $59.25 $194,572 - $345,368	5,829 Added 123.65%	10,543 $367,000
Q3 2021 Nov 15, 2021	BUY	$53.75 - $76.55 $253,377 - $360,856	4,714 New	4,714 $258,000
Q4 2020 Feb 09, 2021	SELL	$48.06 - $84.4 $1.47 Million - $2.58 Million	-30,547 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$46.87 - $93.33 $1.43 Million - $2.85 Million	30,547 New	30,547 $1.45 Million

235

60.7M

726K

329K

Ticker SDGR
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 62,028,400
Market Cap $1.22B
Description
Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences i...

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Seven Eight Capital, LP with notifications on news.